PulmPEEPs

101. RFJC – NAVIGATOR


Listen Later

We’re back with another Rapid Fire Journal Club. Luke Hedrick and Dave Furfaro discuss the NAVIGATOR trial published in NEJM in 2021 evaluating tezepelumab for adults with asthma.

Article and Reference

We are talking today about the NAVIGATOR trial evaluating the use of tezepelumab in adults with asthma.

Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, Brightling CE, Griffiths JM, Hellqvist Å, Bowen K, Kaur P, Almqvist G, Ponnarambil S, Colice G. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384(19):1800-1809. doi: 10.1056/NEJMoa2034975. PMID: 33979488.

https://www.nejm.org/doi/full/10.1056/NEJMoa2034975

Key Learning Points

Background & Rationale

  • Asthma biologics already exist, targeting IgE and type 2 cytokines (IL-4, IL-5, IL-13), but there’s an unmet need for patients with non-allergic or non-eosinophilic phenotypes.
  • Tezepelumab is a monoclonal antibody targeting TSLP (thymic stromal lymphopoietin), an upstream mediator of both T2 and non-T2 inflammation, offering a potentially broader therapeutic effect.
  •  

    Study Design (Navigator Trial)

    • Phase 3, double-blind, placebo-controlled RCT
    • Conducted in 18 countries from 2017-2020
    • N = 1,061 patients, aged 12-80 with moderate to severe asthma
    • All were on medium/high-dose ICS + controller med
    • Required ≥2 exacerbations in prior year
    •  

      Outcomes

      • Primary Outcome: Annualized rate of asthma exacerbations (events per patient-year)
      • Secondary Outcomes:
        • Change in pre-bronchodilator FEV₁
        • Symptoms & quality of life (with predefined MCIDs)
        • Subgroup analyses by eosinophil count, FeNO, and perennial allergen sensitivity
        •  

          Key Inclusion/Exclusion

          • Inclusion: 12-80 years, guideline-based therapy, ≥2 exacerbations
          • Exclusion: recent biologic use, mild/asymptomatic asthma, no reversibility on spirometry
          •  

            Patient Population (Table 1 Summary)

            • Middle-aged, predominantly white, female
            • Poorly controlled severe asthma despite high-intensity therapy
            • ~75% on high-dose ICS, ~10% on oral steroids
            • ~40% had normal FeNO
            • ~60% had eosinophils <300
            • Median IgE ~195
            •  

               Results

              Efficacy:

              • Annualized exacerbation rate:
                • 0.93 (tezepelumab) vs. 2.1 (placebo)
                • Rate ratio: 0.44, p<0.001 (very positive)
                • In eosinophils <300 group: rate ratio 0.59, still effective
                • FEV₁ improved by ~+0.25 L (vs. +0.09 L placebo), significant & sustained from week 2 onward
                • Quality of life: statistically improved but did not meet MCID, so unclear clinical impact
                • Severity of exacerbations reduced: fewer hospitalizations & ED visits in the treatment arm
                • ~40% of treated patients still had some exacerbations → not a cure, but improves severity
                • Safety:

                  • Very well tolerated
                  • 77% reported adverse events (more common in placebo)
                  • No anaphylaxis, no GBS, no cancer signal
                  • Most common AEs: URTI, headache, nasopharyngitis
                  • Injection site reactions: 3.6%
                  • Serious AEs were lower in drug arm than placebo
                  •  

                    Overall Takeaway

                    • Tezepelumab significantly reduces asthma exacerbations (including in patients with low eosinophils), improves lung function, and is safe and well tolerated.
                    • Provides a broad-acting biologic option even for patients who may not be eligible for existing T2-high biologics.
                    • Now widely used as part of the asthma biologic armamentarium for poorly controlled asthma despite maximal inhaled therapy.
                    • Infographic:

                       

                      ...more
                      View all episodesView all episodes
                      Download on the App Store

                      PulmPEEPsBy PulmPEEPs

                      • 4.9
                      • 4.9
                      • 4.9
                      • 4.9
                      • 4.9

                      4.9

                      52 ratings


                      More shows like PulmPEEPs

                      View all
                      EMCrit FOAM Feed by Scott D. Weingart, MD FCCM

                      EMCrit FOAM Feed

                      1,865 Listeners

                      Emergency Medicine Cases by Dr. Anton Helman

                      Emergency Medicine Cases

                      536 Listeners

                      Core EM - Emergency Medicine Podcast by Core EM

                      Core EM - Emergency Medicine Podcast

                      247 Listeners

                      JAMA Clinical Reviews by JAMA Network

                      JAMA Clinical Reviews

                      491 Listeners

                      The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

                      The Curbsiders Internal Medicine Podcast

                      3,326 Listeners

                      Core IM | Internal Medicine Podcast by Core IM Team

                      Core IM | Internal Medicine Podcast

                      1,087 Listeners

                      Annals On Call Podcast by American College of Physicians

                      Annals On Call Podcast

                      185 Listeners

                      The Internet Book of Critical Care Podcast by Adam Thomas & Josh Farkas

                      The Internet Book of Critical Care Podcast

                      694 Listeners

                      The Clinical Problem Solvers by The Clinical Problem Solvers

                      The Clinical Problem Solvers

                      515 Listeners

                      Harrison's PodClass: Internal Medicine Cases and Board Prep by AccessMedicine

                      Harrison's PodClass: Internal Medicine Cases and Board Prep

                      348 Listeners

                      Run the List by Walker Redd, Emily Gutowski, Navin Kumar, Joyce Zhou, Blake Smith

                      Run the List

                      249 Listeners

                      Cardionerds: A Cardiology Podcast by CardioNerds

                      Cardionerds: A Cardiology Podcast

                      420 Listeners

                      Critical Care Scenarios by Brandon Oto, PA-C, FCCM and Bryan Boling, DNP, ACNP, FCCM

                      Critical Care Scenarios

                      247 Listeners

                      The Curious Clinicians by The Curious Clinicians

                      The Curious Clinicians

                      366 Listeners

                      Critical Care Time by Critical Care Time Podcast

                      Critical Care Time

                      219 Listeners